<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">Korean J Anesthesiol</journal-id><journal-id journal-id-type="publisher-id">KJAE</journal-id><journal-title-group><journal-title>Korean Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="ppub">2005-6419</issn><issn pub-type="epub">2005-7563</issn><publisher><publisher-name>The Korean Society of Anesthesiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24624269</article-id><article-id pub-id-type="pmc">3948438</article-id><article-id pub-id-type="doi">10.4097/kjae.2014.66.2.120</article-id><article-categories><subj-group><subject>Clinical Research Article</subject></subj-group></article-categories><title-group><article-title>The effect of a subhypnotic dose of propofol for the prevention of coughing in adults during emergence from anesthesia with sevoflurane and remifentanil</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Soon Yong</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hee Bin</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Ju Deok</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Anesthesiology and Pain Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.</aff><aff id="A2"><label>2</label>Department of Anesthesiology and Pain Medicine, Kosin University College of Medicine, Busan, Korea.</aff><author-notes><corresp>Corresponding author: Ju Deok Kim, M.D., Department of Anesthesiology and Pain Medicine, Kosin University Colledge of Medicine, 34, Amnam-dong, Seo-gu, Busan 602-702, Korea. Tel: 82-51-990-6283, Fax: 82-51-990-6283, <email>uamyfriends@hanmail.net</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>28</day><month>2</month><year>2014</year></pub-date><volume>66</volume><issue>2</issue><fpage>120</fpage><lpage>126</lpage><history><date date-type="received"><day>26</day><month>7</month><year>2013</year></date><date date-type="rev-recd"><day>29</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>30</day><month>8</month><year>2013</year></date></history><permissions><copyright-statement>Copyright Â© the Korean Society of Anesthesiologists, 2014</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3441" xml_f="3451" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3462" xml_f="3734" txt_i="22" txt_f="294">Coughing during emergence from general anesthesia may be detrimental. Propofol is known to inhibit airway reflexes. We evaluated the incidence and severity of coughing in adults who received a subhypnotic dose of propofol at the end of sevoflurane-remifentanil anesthesia.</offsets></p></sec><sec><title><offsets xml_i="3756" xml_f="3763" txt_i="296" txt_f="303">Methods</offsets></title><p><offsets xml_i="3774" xml_f="4300" txt_i="304" txt_f="830">Sixty patients, aged 18-65 years, undergoing elective nasal surgery under general anesthesia using sevoflurane and remifentanil were randomly allocated to the propofol group (n = 30) or the control group (n = 30). At the end of surgery, sevoflurane and remifentanil infusion was stopped. After 3 min, the propofol group received propofol 0.3 mg/kg and the control group received normal saline 0.03 ml/kg. The incidence and severity of cough, recovery time and hemodynamic parameters were evaluated during the emergence period.</offsets></p></sec><sec><title><offsets xml_i="4322" xml_f="4329" txt_i="832" txt_f="839">Results</offsets></title><p><offsets xml_i="4340" xml_f="4656" txt_i="840" txt_f="1156">During emergence, the propofol group had the significantly lower incidence (60 vs. 87%) and severity of coughing compared with the control group (P = 0.04, P = 0.02, respectively). There were no significant differences in mean arterial pressure, heart rate, and recovery time during emergence between the two groups.</offsets></p></sec><sec><title><offsets xml_i="4678" xml_f="4689" txt_i="1158" txt_f="1169">Conclusions</offsets></title><p><offsets xml_i="4700" xml_f="4911" txt_i="1170" txt_f="1381">During emergence from sevoflurane-remifentanil anesthesia, a subhypnotic dose (0.3 mg/kg) of propofol decreases the incidence and severity of coughing without delaying wake up in adults undergoing nasal surgery.</offsets></p></sec></abstract><kwd-group><kwd>Cough</kwd><kwd>Emergence</kwd><kwd>Propofol</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="5051" xml_f="5063" txt_i="1390" txt_f="1402">Introduction</offsets></title><p><offsets xml_i="5074" xml_f="5245" txt_i="1403" txt_f="1574">Coughing caused by irritation from an endotracheal tube frequently occurs during emergence from general anesthesia, and the incidence of cough is reported from 38 to 96% [</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="5276" xml_f="5277" txt_i="1574" txt_f="1575">1</offsets></xref><offsets xml_i="5284" xml_f="5285" txt_i="1575" txt_f="1576">-</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="5316" xml_f="5317" txt_i="1576" txt_f="1577">3</offsets></xref><offsets xml_i="5324" xml_f="5565" txt_i="1577" txt_f="1818">]. Such coughing can cause hypertension, tachyarrhythmia and various complications can occur including a subsequent increase in intracranial pressure, bleeding in the operated site, and disruption of surgical wounds from excessive movement [</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="5596" xml_f="5597" txt_i="1818" txt_f="1819">4</offsets></xref><offsets xml_i="5604" xml_f="5605" txt_i="1819" txt_f="1820">,</offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="5636" xml_f="5637" txt_i="1820" txt_f="1821">5</offsets></xref><offsets xml_i="5644" xml_f="5793" txt_i="1821" txt_f="1970">]. Various methods have been studied to prevent coughing during emergence from general anesthesia, such as extubation in a deep plane of anesthesia [</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="5824" xml_f="5825" txt_i="1970" txt_f="1971">6</offsets></xref><offsets xml_i="5832" xml_f="5872" txt_i="1971" txt_f="2011">], intra-cuff application of lidocaine [</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="5903" xml_f="5904" txt_i="2011" txt_f="2012">1</offsets></xref><offsets xml_i="5911" xml_f="5932" txt_i="2012" txt_f="2033">] or i.v. lidocaine [</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="5963" xml_f="5964" txt_i="2033" txt_f="2034">7</offsets></xref><offsets xml_i="5971" xml_f="6013" txt_i="2034" txt_f="2076">], and administration of dexmedetomidine [</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="6044" xml_f="6045" txt_i="2076" txt_f="2077">8</offsets></xref><offsets xml_i="6052" xml_f="6072" txt_i="2077" txt_f="2097">] and remifentanil [</offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="6103" xml_f="6104" txt_i="2097" txt_f="2098">9</offsets></xref><offsets xml_i="6111" xml_f="6112" txt_i="2098" txt_f="2099">,</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="6144" xml_f="6146" txt_i="2099" txt_f="2101">10</offsets></xref><offsets xml_i="6153" xml_f="6261" txt_i="2101" txt_f="2209">]. These methods have various advantages, but they also have drawbacks so their clinical use can be limited.</offsets></p><p><offsets xml_i="6268" xml_f="6371" txt_i="2210" txt_f="2313">Propofol is used widely in clinical anesthesia, and it is known to be an inhibitor of airway reflexes [</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="6403" xml_f="6405" txt_i="2313" txt_f="2315">11</offsets></xref><offsets xml_i="6412" xml_f="6658" txt_i="2315" txt_f="2561">]. Recently, there have been reports that patients who received total intravenous anesthesia (TIVA) using propofol showed less prevalence of coughing during emergence compared to patients who received balanced anesthesia (BAL) using sevoflurane [</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="6690" xml_f="6692" txt_i="2561" txt_f="2563">12</offsets></xref><offsets xml_i="6699" xml_f="6700" txt_i="2563" txt_f="2564">,</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="6732" xml_f="6734" txt_i="2564" txt_f="2566">13</offsets></xref><offsets xml_i="6741" xml_f="6922" txt_i="2566" txt_f="2747">]. In addition, it has been reported that single i.v. administration of a subhypnotic dose of propofol effectively prevented laryngospasm and coughing during emergence in children [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="6954" xml_f="6956" txt_i="2747" txt_f="2749">14</offsets></xref><offsets xml_i="6963" xml_f="6964" txt_i="2749" txt_f="2750">,</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="6996" xml_f="6998" txt_i="2750" txt_f="2752">15</offsets></xref><offsets xml_i="7005" xml_f="7225" txt_i="2752" txt_f="2972">]. However, there are no studies yet on the effect of administering a subhypnotic dose of propofol for coughing and on the recovery time during emergence in adults who were anesthetized with sevoflurane and remifentanil.</offsets></p><p><offsets xml_i="7232" xml_f="7597" txt_i="2973" txt_f="3338">Therefore, this study was conducted to examine whether single administration of a subhypnotic dose of propofol can reduce the incidence and severity of coughing in adults during emergence from general anesthesia when using sevoflurane and remifentanil. In addition, the effect of propofol administration on the recovery time and hemodynamics of adults was examined.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="7648" xml_f="7669" txt_i="3340" txt_f="3361">Materials and Methods</offsets></title><p><offsets xml_i="7680" xml_f="8368" txt_i="3362" txt_f="4050">This study was approved by the Institutional Ethics Committee, and written informed consent was obtained from the patients. Among patients who were scheduled for elective nasal surgery under general anesthesia, 60 patients of American Society of Anesthesiologists physical status I-II and age 18-65 were chosen as subjects. Patients with anticipated difficulty in endotracheal intubation, and patients with mental, neurologic, cardiovascular, lung, or kidney disease were excluded as research subjects. In addition, in the pre-operative visit, patients wearing hearing aids due to some hearing disturbance or unable to have conversations in a normal voice were excluded as study subjects.</offsets></p><p><offsets xml_i="8375" xml_f="8835" txt_i="4051" txt_f="4511">Using computer-generated random numbers, the patients were divided into two groups according to the administration of propofol or normal saline. Propofol 0.3 mg/kg for the propofol group (n = 30) and normal saline 0.03 ml/kg for the control group (n = 30) were prepared at the completion of the surgery by the authors who did not participate in the anesthesia, and the syringes were wrapped with white tape to hide the color difference between the study drugs.</offsets></p><p><offsets xml_i="8842" xml_f="9217" txt_i="4512" txt_f="4887">All patients fasted for 8 hours before the operation, and were premedicated with i.m. midazolam 2.5 mg before induction. Upon arrival in the operating room, electrocardiogram, non-invasive blood pressure (Philips MP40), pulse oximeter, bispectral index (BIS) (BISâ¢ quarto, Covidien, Mansfield, MA, USA), and tympanic thermometer were used to monitor vital sign and BIS value.</offsets></p><p><offsets xml_i="9224" xml_f="10355" txt_i="4888" txt_f="6019">Before induction, lactated Ringer's solution 5 ml/kg was administered for 5 minutes and preoxygenation was conducted with 100% oxygen. After i.v. administrating glycopyrrolate 0.2 mg, remifentanil 0.5 Âµg/kg and propofol 1.5 mg/kg were i.v. administered to induce anesthesia. Rocuronium 0.8 mg/kg was i.v. administrated to induce muscle relaxation, and endotracheal intubation was conducted using endotracheal tube with an internal diameter of 8.0 mm for males and 7.0 mm for females. Then a hand pressure gauge (Hi-Loâ¢ Hand Pressure Gauge, VBM Medizintechnik GmbH, Sulz a.N., Baden-WÃ¼rttemberg, Germany) was used to fill with air until the cuff pressure reached 20-25 mmHg, and the pressure was maintained at 20-25 mmHg until the surgery ended. Anesthesia was maintained with continuous infusion of remifentanil 0.05-0.20 Âµg/kg/min and sevoflurane 1.5-2.5%. Throughout the surgery, depth of anesthesia was titrated to maintain a BIS value between 45 and 65, and the mean arterial pressure (MAP) and heart rate (HR) were maintained within Â± 20% of the pre-induction values. Mechanical ventilation was controlled to maintain the ETCO</offsets><sub><offsets xml_i="10360" xml_f="10361" txt_i="6019" txt_f="6020">2</offsets></sub><offsets xml_i="10367" xml_f="10428" txt_i="6020" txt_f="6081"> at 30-35 mmHg, and the temperature was maintained at 36-37â.</offsets></p><p><offsets xml_i="10435" xml_f="11087" txt_i="6082" txt_f="6734">Two anesthesiologists who were unaware of the patient groups participated during the emergence phase. The entire procedure from anesthesia induction to emergence was conducted by a skilled anesthesiologist, and measurements such as MAP, occurrence of coughing, and severity of coughing were recorded by another anesthesiologist. Five minutes before the end of surgery, the concentration of sevoflurane was adjusted to 1.0% and remifentanil to 0.03 Âµg/kg/min for both groups until the end of surgery. In addition, ketorolac 0.5 mg/kg was administered for postoperative pain control, and ramosetron HCl 0.3 mg to reduce postoperative nausea and vomiting.</offsets></p><p><offsets xml_i="11094" xml_f="11805" txt_i="6735" txt_f="7446">After the completion of surgery, blood and secretions in the oral cavity were gently suctioned, and sevoflurane and remifentanil were discontinued. Afterwards, mechanical ventilation was discontinued while manual ventilation was performed with 5 L/min oxygen. When train-of-four response was measured at 90% or more, glycopyrrolate 8 Âµg/kg and pyridostigmine 0.2 mg/kg were i.v. administered to reverse the residual neuromuscular blockade. Three minutes after discontinuing sevoflurane and remifentanil, a nurse who was unaware of the patient groups i.v. injected the previously prepared study drugs for 10 seconds (propofol 0.3 mg/kg for the propofol group and normal saline 0.03 ml/kg for the control group) (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11835" xml_f="11841" txt_i="7446" txt_f="7452">Fig. 1</offsets></xref><offsets xml_i="11848" xml_f="11850" txt_i="7452" txt_f="7454">).</offsets></p><p><offsets xml_i="11857" xml_f="12159" txt_i="7455" txt_f="7757">Extubation of the endotracheal tube was performed when the patient followed oral commands of "Open your eyes" and showed regular spontaneous respiration, or when the patient attempted self-extubation. Five minutes after extubation, the patients were transported to the post-anesthesia care unit (PACU).</offsets></p><p><offsets xml_i="12166" xml_f="12588" txt_i="7758" txt_f="8180">The time taken from discontinuing the anesthesia to opening the eyes in response to oral command, and to extubation was recorded. Occurrence and grade of coughing were measured in the operating room from the discontinuation of anesthetic drugs to 5 min after extubation. The grade of coughing was measured in 4 grades, where an additional no cough grade was added to the 3-grade scale used in the study of Minogue et al. [</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="12620" xml_f="12622" txt_i="8180" txt_f="8182">16</offsets></xref><offsets xml_i="12629" xml_f="12787" txt_i="8182" txt_f="8337">] (Grade 0; no cough, Grade 1; single cough, Grade 2; more than one episode of unsustained [â¤ 5 s] coughing, Grade 3; sustained [&gt; 5 s] bouts of coughing).</offsets></p><p><offsets xml_i="12794" xml_f="13154" txt_i="8338" txt_f="8698">The BIS value was measured at the point of discontinuing the anesthetic drug, immediately before and after extubation, 5 minutes after extubation, and 10 minutes after PACU. At the time points of 5 minutes after extubation and 10 minutes after PACU, the grade of sedation was additionally measured according to the following grading system used by Lee et al. [</offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="13185" xml_f="13186" txt_i="8698" txt_f="8699">9</offsets></xref><offsets xml_i="13193" xml_f="13574" txt_i="8699" txt_f="9080">]: Grade 0 was deep sedation where there was no response to a loud voice calling the patient's name and "Open your eyes"; Grade 1 was when the patient was sedated but opened their eyes when called in a loud voice; Grade 2 was when the patient was sedated but opened their eyes when called in a normal voice, and Grade 3 was when the patient opened their eyes and showed a response.</offsets></p><p><offsets xml_i="13581" xml_f="13953" txt_i="9081" txt_f="9453">MAP and HR were measured before induction, at the discontinuation of the anesthetic drugs, immediately before and after extubation, 5 minutes after extubation, and 10 minutes after PACU. In addition, while in the PACU, occurrence of respiratory depression, headache, dizziness or nausea, vomiting, discomfort such as pain of VAS 5 or more, and complications were recorded.</offsets></p><p><offsets xml_i="13960" xml_f="14101" txt_i="9454" txt_f="9595">The sample size was determined by referring previous studies which reported that the incidence of coughing after general anesthesia was 76% [</offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="14132" xml_f="14133" txt_i="9595" txt_f="9596">3</offsets></xref><offsets xml_i="14140" xml_f="14412" txt_i="9596" txt_f="9868">]. When it was hypothesized that using propofol would reduce the occurrence of coughing to 50%, 25 patients are needed per group for a power analysis of 0.8 (Î± = 0.05, Î² = 0.2). Here, in anticipation of dropout, 30 patients per group, 60 patients in total, was determined.</offsets></p><p><offsets xml_i="14419" xml_f="15219" txt_i="9869" txt_f="10669">PASW Statistics 18.0 software (SPSS Inc, Chicago, IL, USA) was used for all statistical analyses. To test the normality of the distribution of the continuous variables, the Shapiro-Wilk test was done. The normally distributed data were compared between the groups with two-tailed unpaired, Student's t-test and expressed as the mean Â± SD. Non-normally distributed variables were evaluated with the Mann-Whitey U test and expressed as the median and interquartile range. The categorical data were analyzed with the Chi-square test or the Fisher's exact test as appropriate. The repeated-measures analysis of variance was used for evaluated the change in MAP, HR, and BIS between the groups according to time. Results were considered to be statistically significant when the P value was less than 0.05.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="15260" xml_f="15267" txt_i="10671" txt_f="10678">Results</offsets></title><p><offsets xml_i="15278" xml_f="15424" txt_i="10679" txt_f="10825">There were no differences between the groups in demographic characteristics, type of surgery, duration of anesthesia, and mean remifentanil dose (</offsets><xref ref-type="table" rid="T1"><offsets xml_i="15456" xml_f="15463" txt_i="10825" txt_f="10832">Table 1</offsets></xref><offsets xml_i="15470" xml_f="15472" txt_i="10832" txt_f="10834">).</offsets></p><p><offsets xml_i="15479" xml_f="15749" txt_i="10835" txt_f="11105">The incidence of coughing during emergence was significantly lower in the propofol group compared to the control group (60 vs 87%, P = 0.04). The grade of coughing during emergence was also significantly lower in the propofol group than in the control group (P = 0.02) (</offsets><xref ref-type="table" rid="T2"><offsets xml_i="15781" xml_f="15788" txt_i="11105" txt_f="11112">Table 2</offsets></xref><offsets xml_i="15795" xml_f="15797" txt_i="11112" txt_f="11114">).</offsets></p><p><offsets xml_i="15804" xml_f="16292" txt_i="11115" txt_f="11603">The time period from the discontinuation of the anesthetic drugs to opening of the eyes was 10.6 Â± 3.5 minutes in the propofol group and 10.4 Â± 3.9 minutes in the control group. The time taken until extubation for the propofol group was 11.8 Â± 3.4 minutes and 11.4 Â± 3.8 minutes for the control group, so there were no statistically significant differences. There was also no difference in the grade of sedation between the groups at 5 minutes after extubation and 10 minutes after PACU (</offsets><xref ref-type="table" rid="T3"><offsets xml_i="16324" xml_f="16331" txt_i="11603" txt_f="11610">Table 3</offsets></xref><offsets xml_i="16338" xml_f="16586" txt_i="11610" txt_f="11858">). The BIS value at the discontinuation of the anesthetic drugs also did not show a significant difference between the groups (P = 0.25). There were also no differences between the two groups in the subsequent changes according to time (P = 0.85) (</offsets><xref ref-type="fig" rid="F2"><offsets xml_i="16616" xml_f="16622" txt_i="11858" txt_f="11864">Fig. 2</offsets></xref><offsets xml_i="16629" xml_f="16631" txt_i="11864" txt_f="11866">).</offsets></p><p><offsets xml_i="16638" xml_f="16884" txt_i="11867" txt_f="12113">The HR and MAP before induction did not show a significant difference between the two groups (P = 0.53, 0.10). The subsequent change in HR according to time during emergence was also not significantly different between the two groups (P = 0.23) (</offsets><xref ref-type="fig" rid="F3"><offsets xml_i="16914" xml_f="16920" txt_i="12113" txt_f="12119">Fig. 3</offsets></xref><offsets xml_i="16927" xml_f="17055" txt_i="12119" txt_f="12247">). There was also no significant difference between the groups for change in MAP according to time during emergence (P = 0.22) (</offsets><xref ref-type="fig" rid="F4"><offsets xml_i="17085" xml_f="17091" txt_i="12247" txt_f="12253">Fig. 4</offsets></xref><offsets xml_i="17098" xml_f="17100" txt_i="12253" txt_f="12255">).</offsets></p><p><offsets xml_i="17107" xml_f="17403" txt_i="12256" txt_f="12552">In the PACU, 1 patient in the control group complained of pain with a VAS score of 5, so fentanyl 50 Âµg, was i.v. administered and there were no such cases in the propofol group. Complications such as respiratory depression, headache, dizziness, nausea, and vomiting did not occur in both groups.</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="17447" xml_f="17457" txt_i="12554" txt_f="12564">Discussion</offsets></title><p><offsets xml_i="17468" xml_f="17980" txt_i="12565" txt_f="13077">In this study, patients who underwent nasal surgery with anesthesia maintained by sevoflurane and remifentanil had significantly reduced an incidence and severity of coughing during emergence without extending the recovery time, when a single dose of propofol 0.3 mg/kg was administered 3 minutes after discontinuing anesthetic drugs. Such results are similar to a report that the incidence of coughing was reduced in children when propofol 0.25 mg/kg was used 1 minute before extubation (53 vs 83%, P = 0.047) [</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="18012" xml_f="18014" txt_i="13077" txt_f="13079">15</offsets></xref><offsets xml_i="18021" xml_f="18023" txt_i="13079" txt_f="13081">].</offsets></p><p><offsets xml_i="18030" xml_f="18186" txt_i="13082" txt_f="13238">Coughing during emergence is caused by activation of the sensitive ascending vagus nerve distributed in the airway from chemical and mechanical irritation [</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="18218" xml_f="18220" txt_i="13238" txt_f="13240">17</offsets></xref><offsets xml_i="18227" xml_f="18440" txt_i="13240" txt_f="13453">]. Additionally, it is known that other ascending nerve subtypes and visceral organ, chest wall, diaphragm, and abdominal muscles controlled by the nerve also play an important role in the occurrence of coughing [</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="18472" xml_f="18474" txt_i="13453" txt_f="13455">18</offsets></xref><offsets xml_i="18481" xml_f="18573" txt_i="13455" txt_f="13547">]. Propofol reduces the reflexes of the larynx and airway in proportion to the amount used [</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="18605" xml_f="18607" txt_i="13547" txt_f="13549">11</offsets></xref><offsets xml_i="18614" xml_f="18700" txt_i="13549" txt_f="13635">], and such an effect can appear further accelerated when used together with opioids [</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="18732" xml_f="18734" txt_i="13635" txt_f="13637">19</offsets></xref><offsets xml_i="18741" xml_f="18909" txt_i="13637" txt_f="13805">]. In addition, the effect of propofol on the central nervous system is to enhance the Î³-aminobutyrateA (GABA) induced chloride current through its binding to the GABA </offsets><sub><offsets xml_i="18914" xml_f="18915" txt_i="13805" txt_f="13806">A</offsets></sub><offsets xml_i="18921" xml_f="18932" txt_i="13806" txt_f="13817"> receptor [</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="18964" xml_f="18966" txt_i="13817" txt_f="13819">20</offsets></xref><offsets xml_i="18973" xml_f="19059" txt_i="13819" txt_f="13905">]. In addition, propofol controls sodium channel gating and subsequently inhibits the </offsets><italic><offsets xml_i="19067" xml_f="19068" txt_i="13905" txt_f="13906">N</offsets></italic><offsets xml_i="19077" xml_f="19139" txt_i="13906" txt_f="13968">-methyl-D-aspartate (NMDA) subtype of the glutamate receptor [</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="19171" xml_f="19173" txt_i="13968" txt_f="13970">21</offsets></xref><offsets xml_i="19180" xml_f="19279" txt_i="13970" txt_f="14069">]. There are reports that the occurrence of coughing was reduced when NMDA receptors were blocked [</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="19311" xml_f="19313" txt_i="14069" txt_f="14071">22</offsets></xref><offsets xml_i="19320" xml_f="19321" txt_i="14071" txt_f="14072">,</offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="19353" xml_f="19355" txt_i="14072" txt_f="14074">23</offsets></xref><offsets xml_i="19362" xml_f="19624" txt_i="14074" txt_f="14336">], so the inhibition of NMDA receptors by propofol may have reduced the occurrence of coughing. However, in children, propofol had a better effect in the suppression of coughing during emergence than that of ketamine known as the representative NMDA antagonist [</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="19656" xml_f="19658" txt_i="14336" txt_f="14338">15</offsets></xref><offsets xml_i="19665" xml_f="19864" txt_i="14338" txt_f="14537">]. Considering these points, the NMDA inhibition effect of propofol is less likely to be the main mechanism for supressing coughing, and there is need for more clinical studies regarding this matter.</offsets></p><p><offsets xml_i="19871" xml_f="20000" txt_i="14538" txt_f="14667">A single i.v. injection of propofol during emergence is usually used in children to reduce laryngospasm and emergence agitation [</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="20032" xml_f="20034" txt_i="14667" txt_f="14669">14</offsets></xref><offsets xml_i="20041" xml_f="20042" txt_i="14669" txt_f="14670">,</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="20074" xml_f="20076" txt_i="14670" txt_f="14672">15</offsets></xref><offsets xml_i="20083" xml_f="20084" txt_i="14672" txt_f="14673">,</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="20116" xml_f="20118" txt_i="14673" txt_f="14675">24</offsets></xref><offsets xml_i="20125" xml_f="20504" txt_i="14675" txt_f="15054">], but there have been no reports yet on the effect of a subhypnotic dose of propofol during emergence on coughing and the recovery profile of adults whose anesthesia was maintained with sevoflurane and remifentanil. Therefore, to obtain the desired effect of propofol in adults during emergence, the administration dosage and time have to be determined carefully. Aouad et al. [</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="20536" xml_f="20538" txt_i="15054" txt_f="15056">24</offsets></xref><offsets xml_i="20545" xml_f="20826" txt_i="15056" txt_f="15337">] reported that emergence agitation was reduced in children when a single dose of propofol 1.0 mg/kg was administered at the end of surgery, but the recovery time was significantly delayed around 4 minutes compared to when propofol was not administered. In addition, Cohen et al. [</offsets><xref rid="B25" ref-type="bibr"><offsets xml_i="20858" xml_f="20860" txt_i="15337" txt_f="15339">25</offsets></xref><offsets xml_i="20867" xml_f="21393" txt_i="15339" txt_f="15865">] reported that when propofol 2 mg/kg was administered in addition to inhalation anesthesia in children before the start of surgery, it did not reduce emergence agitation. This result can be because the effect of propofol administered at the start of surgery was not continued until emergence. Our research referred to previous studies which reported that it took approximately 7.2-12 minutes from the time of discontinuing anesthetic drugs to extubation when anesthesia had been maintained with sevoflurane and remifentanil [</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="21425" xml_f="21427" txt_i="15865" txt_f="15867">12</offsets></xref><offsets xml_i="21434" xml_f="21435" txt_i="15867" txt_f="15868">,</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="21467" xml_f="21469" txt_i="15868" txt_f="15870">13</offsets></xref><offsets xml_i="21476" xml_f="21790" txt_i="15870" txt_f="16184">]. Accordingly, the authors decided to administer 0.3 mg/kg of propofol as a single dose 3 minutes after discontinuing the anesthetic drugs. The dosage was a 10 minute-dose of the continuous infusion rate, which was 30 Âµg/kg/min, needed for the hypnotic effect-the effective dosage ranged from 30 to 60 Âµg/kg/min [</offsets><xref rid="B26" ref-type="bibr"><offsets xml_i="21822" xml_f="21824" txt_i="16184" txt_f="16186">26</offsets></xref><offsets xml_i="21831" xml_f="22293" txt_i="16186" txt_f="16648">]. In our study, there were no patients who showed an emergence response before administering the propofol, which was in 3 minutes after discontinuing the anesthetic drugs. The time taken for eye-opening and extubation was 20 seconds longer in the propofol group compared to the control group. However this was not statistically significant. Although a direct comparison is difficult because the pharmacodynamics of propofol is different in adults and children [</offsets><xref rid="B27" ref-type="bibr"><offsets xml_i="22325" xml_f="22327" txt_i="16648" txt_f="16650">27</offsets></xref><offsets xml_i="22334" xml_f="22462" txt_i="16650" txt_f="16778">], the dosage of propofol used in this study was smaller (0.3 mg/kg) than the amount used in the study on children (1.0 mg/kg) [</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="22494" xml_f="22496" txt_i="16778" txt_f="16780">24</offsets></xref><offsets xml_i="22503" xml_f="22575" txt_i="16780" txt_f="16852">]. Therefore, we think that there was less effect on delaying emergence.</offsets></p><p><offsets xml_i="22582" xml_f="23705" txt_i="16853" txt_f="17976">In our study, the BIS value showed a slight decline immediately after administering propofol, but the BIS value was similar to the control group at the time of eye opening, extubation, 5 minutes after extubation, and 10 minutes after PACU. In addition, most of the propofol group were awake or opened their eyes in response to a normal voice at 5 minutes after extubation, and at 10 minutes after PACU. At both time points, there was no difference compared to the control group. However, there were 2 patients in the propofol group who showed sedation of Grade 1, where they did not respond to a normal voice but responded to a loud voice, at 5 minutes after extubation, while all the patients in the control group were Grade 2 or higher where they responded even to a normal voice. Although no patient showed respiratory depression in our study, the effect of sedation appeared differently even for propofol 0.3 mg/kg due to individual differences. Therefore, when administrating propofol during emergence, there is a need for careful monitoring taking into consideration the sedation of patients when transported to PACU.</offsets></p><p><offsets xml_i="23712" xml_f="23828" txt_i="17977" txt_f="18093">Propofol can significantly decrease the arterial pressure according to the dosage used during anesthetic induction [</offsets><xref rid="B28" ref-type="bibr"><offsets xml_i="23860" xml_f="23862" txt_i="18093" txt_f="18095">28</offsets></xref><offsets xml_i="23869" xml_f="23870" txt_i="18095" txt_f="18096">,</offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="23902" xml_f="23904" txt_i="18096" txt_f="18098">29</offsets></xref><offsets xml_i="23911" xml_f="24095" txt_i="18098" txt_f="18282">], and this appears in relation to systemic vascular resistance and a decrease in cardiac output. In addition, it does not have a significant direct effect on HR, but it may increase [</offsets><xref rid="B30" ref-type="bibr"><offsets xml_i="24127" xml_f="24129" txt_i="18282" txt_f="18284">30</offsets></xref><offsets xml_i="24136" xml_f="24783" txt_i="18284" txt_f="18931">]. In our study, the MAP and HR increased in both groups from the discontinuation of anesthetic drugs to 10 minutes in PACU compared to before induction. Additionally, compared to the control group, the propofol group showed a slightly high MAP from the discontinuation of anesthetic drugs to 10 minutes in PACU, but no significant difference was found between the two groups. Additionally, the change in HR was not significantly different between the two groups. These results are considered to be because only a small dose of propofol was used in this study, and it did not have a significant effect on the change in MAP and HR during emergence.</offsets></p><p><offsets xml_i="24790" xml_f="25119" txt_i="18932" txt_f="19261">The limitation of this study is that first, the concentration of sevoflurane was not measured at the end of surgery, so the effect from the difference in concentration of anesthetic drugs during emergence cannot be excluded. In addition, low-dose remifentanil during emergence has been reported to effectively suppress coughing [</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="25151" xml_f="25153" txt_i="19261" txt_f="19263">11</offsets></xref><offsets xml_i="25160" xml_f="26096" txt_i="19263" txt_f="20199">], so although it was discontinued after the end of surgery, it cannot be concluded that the residual effect of remifentanil had no effect on the incidence and severity of coughing in both groups. Although the concentration of sevoflurane was not measured during emergence in this study, the depth of anesthesia was controlled during the anesthesia maintenance by monitoring vital signs and BIS values, and the concentration of sevoflurane and dosage of remifentanil was equal in both groups from 5 minutes before to the end of surgery. Through this, variables that could cause differences in the emergence time were minimized. In addition, more helpful results regarding the effect on coughing during emergence could have been obtained if the study was conducted with an additional group where remifentanil was continued. It is a limitation that this was overlooked, and further study is considered to be necessary regarding this area.</offsets></p><p><offsets xml_i="26103" xml_f="26569" txt_i="20200" txt_f="20666">Another limitation of our study is that it was limited to patients receiving nasal surgery, and hence, it cannot predict the coughing suppression effect of propofol during emergence in patients receiving different surgeries. The factors that affect emergence can be diverse according to the type of surgery. Therefore, the study range should be expanded to examine the effect of administering propofol during emergence in patients receiving various types of surgery.</offsets></p><p><offsets xml_i="26576" xml_f="26859" txt_i="20667" txt_f="20950">In conclusion, a single dose of propofol 0.3 mg/kg administered at 3 minutes after discontinuing anesthetic drugs significantly reduced the incidence and severity of coughing during emergence in patients who received nasal surgery when anesthetized with sevoflurane and remifentanil.</offsets></p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagan</surname><given-names>C</given-names></name><name><surname>Frizelle</surname><given-names>HP</given-names></name><name><surname>Laffey</surname><given-names>J</given-names></name><name><surname>Hannon</surname><given-names>V</given-names></name><name><surname>Carey</surname><given-names>M</given-names></name></person-group><article-title>The effects of intracuff lidocaine on endotracheal tube induced emergence phenomena after general anesthesia</article-title><source>Anesth Analg</source><year>2000</year><volume>91</volume><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">10866913</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>RM</given-names></name><name><surname>Bjerke</surname><given-names>RJ</given-names></name><name><surname>Drobycki</surname><given-names>T</given-names></name><name><surname>Stapelfeldt</surname><given-names>WH</given-names></name><name><surname>Green</surname><given-names>JM</given-names></name><name><surname>Janowitz</surname><given-names>MJ</given-names></name><etal></etal></person-group><article-title>Prevention of endotracheal tube-induced coughing during emergence from general anesthesia</article-title><source>Anesth Analg</source><year>1994</year><volume>79</volume><fpage>792</fpage><lpage>795</lpage><pub-id pub-id-type="pmid">7943794</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Bishop</surname><given-names>MJ</given-names></name></person-group><article-title>Cough during emergence from isoflurane anesthesia</article-title><source>Anesth Analg</source><year>1998</year><volume>87</volume><fpage>1170</fpage><lpage>1174</lpage><pub-id pub-id-type="pmid">9806703</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irwin</surname><given-names>RS</given-names></name></person-group><article-title>Complications of cough: ACCP evidence-based clinical practice guidelines</article-title><source>Chest</source><year>2006</year><volume>129</volume><issue>1 Suppl</issue><fpage>54S</fpage><lpage>58S</lpage><pub-id pub-id-type="pmid">16428692</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leech</surname><given-names>P</given-names></name><name><surname>Barker</surname><given-names>J</given-names></name><name><surname>Fitch</surname><given-names>W</given-names></name></person-group><article-title>Proceedings: Changes in intracranial pressure and systemic arterial pressure during the termination of anaesthesia</article-title><source>Br J Anaesth</source><year>1974</year><volume>46</volume><fpage>315</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">4451611</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neelakanta</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name></person-group><article-title>Minimum alveolar concentration of isoflurane for tracheal extubation in deeply anesthetized children</article-title><source>Anesthesiology</source><year>1994</year><volume>80</volume><fpage>811</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">8024135</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatesan</surname><given-names>T</given-names></name><name><surname>Korula</surname><given-names>G</given-names></name></person-group><article-title>A comparative study between the effects of 4% endotracheal tube cuff lignocaine and 1.5 mg/kg intravenous lignocaine on coughing and hemodynamics during extubation in neurosurgical patients: a randomized controlled double-blind trial</article-title><source>J Neurosurg Anesthesiol</source><year>2006</year><volume>18</volume><fpage>230</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">17006119</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guler</surname><given-names>G</given-names></name><name><surname>Akin</surname><given-names>A</given-names></name><name><surname>Tosun</surname><given-names>Z</given-names></name><name><surname>Eskitascoglu</surname><given-names>E</given-names></name><name><surname>Mizrak</surname><given-names>A</given-names></name><name><surname>Boyaci</surname><given-names>A</given-names></name></person-group><article-title>Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation</article-title><source>Acta Anaesthesiol Scand</source><year>2005</year><volume>49</volume><fpage>1088</fpage><lpage>1091</lpage><pub-id pub-id-type="pmid">16095449</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Koo</surname><given-names>BN</given-names></name><name><surname>Jeong</surname><given-names>JJ</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name></person-group><article-title>Differential effects of lidocaine and remifentanil on response to the tracheal tube during emergence from general anaesthesia</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><fpage>410</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">21205628</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aouad</surname><given-names>MT</given-names></name><name><surname>Al-Alami</surname><given-names>AA</given-names></name><name><surname>Nasr</surname><given-names>VG</given-names></name><name><surname>Souki</surname><given-names>FG</given-names></name><name><surname>Zbeidy</surname><given-names>RA</given-names></name><name><surname>Siddik-Sayyid</surname><given-names>SM</given-names></name></person-group><article-title>The effect of low-dose remifentanil on responses to the endotracheal tube during emergence from general anesthesia</article-title><source>Anesth Analg</source><year>2009</year><volume>108</volume><fpage>1157</fpage><lpage>1160</lpage><pub-id pub-id-type="pmid">19299779</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKeating</surname><given-names>K</given-names></name><name><surname>Bali</surname><given-names>IM</given-names></name><name><surname>Dundee</surname><given-names>JW</given-names></name></person-group><article-title>The effects of thiopentone and propofol on upper airway integrity</article-title><source>Anaesthesia</source><year>1988</year><volume>43</volume><fpage>638</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">3262318</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohlrieder</surname><given-names>M</given-names></name><name><surname>Tiefenthaler</surname><given-names>W</given-names></name><name><surname>Klaus</surname><given-names>H</given-names></name><name><surname>Gabl</surname><given-names>M</given-names></name><name><surname>Kavakebi</surname><given-names>P</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Effect of total intravenous anaesthesia and balanced anaesthesia on the frequency of coughing during emergence from the anaesthesia</article-title><source>Br J Anaesth</source><year>2007</year><volume>99</volume><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">17660457</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hans</surname><given-names>P</given-names></name><name><surname>Marechal</surname><given-names>H</given-names></name><name><surname>Bonhomme</surname><given-names>V</given-names></name></person-group><article-title>Effect of propofol and sevoflurane on coughing in smokers and non-smokers awakening from general anaesthesia at the end of a cervical spine surgery</article-title><source>Br J Anaesth</source><year>2008</year><volume>101</volume><fpage>731</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">18818191</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batra</surname><given-names>YK</given-names></name><name><surname>Ivanova</surname><given-names>M</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name><name><surname>Shamsah</surname><given-names>M</given-names></name><name><surname>Al Qattan</surname><given-names>AR</given-names></name><name><surname>Belani</surname><given-names>KG</given-names></name></person-group><article-title>The efficacy of a subhypnotic dose of propofol in preventing laryngospasm following tonsillectomy and adenoidectomy in children</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>1094</fpage><lpage>1097</lpage><pub-id pub-id-type="pmid">16324030</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Ji</surname><given-names>SM</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name></person-group><article-title>Effect of a small dose of propofol or ketamine to prevent coughing and laryngospasm in children awakening from general anesthesia</article-title><source>Korean J Anesthesiol</source><year>2011</year><volume>60</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">21359077</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minogue</surname><given-names>SC</given-names></name><name><surname>Ralph</surname><given-names>J</given-names></name><name><surname>Lampa</surname><given-names>MJ</given-names></name></person-group><article-title>Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia</article-title><source>Anesth Analg</source><year>2004</year><volume>99</volume><fpage>1253</fpage><lpage>1257</lpage><pub-id pub-id-type="pmid">15385385</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widdicombe</surname><given-names>JG</given-names></name></person-group><article-title>Afferent receptors in the airways and cough</article-title><source>Respir Physiol</source><year>1998</year><volume>114</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9858046</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canning</surname><given-names>BJ</given-names></name></person-group><article-title>Anatomy and neurophysiology of the cough reflex: ACCP evidence-based clinical practice guidelines</article-title><source>Chest</source><year>2006</year><volume>129</volume><issue>1 Suppl</issue><fpage>33S</fpage><lpage>47S</lpage><pub-id pub-id-type="pmid">16428690</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagaito</surname><given-names>Y</given-names></name><name><surname>Isono</surname><given-names>S</given-names></name><name><surname>Nishino</surname><given-names>T</given-names></name></person-group><article-title>Upper airway reflexes during a combination of propofol and fentanyl anesthesia</article-title><source>Anesthesiology</source><year>1998</year><volume>88</volume><fpage>1459</fpage><lpage>1466</lpage><pub-id pub-id-type="pmid">9637637</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasowski</surname><given-names>MD</given-names></name><name><surname>Nishikawa</surname><given-names>K</given-names></name><name><surname>Nikolaeva</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Harrison</surname><given-names>NL</given-names></name></person-group><article-title>Methionine 286 in transmembrane domain 3 of the GABAA receptor beta subunit controls a binding cavity for propofol and other alkylphenol general anesthetics</article-title><source>Neuropharmacology</source><year>2001</year><volume>41</volume><fpage>952</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">11747900</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orser</surname><given-names>BA</given-names></name><name><surname>Bertlik</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>MacDonald</surname><given-names>JF</given-names></name></person-group><article-title>Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones</article-title><source>Br J Pharmacol</source><year>1995</year><volume>116</volume><fpage>1761</fpage><lpage>1768</lpage><pub-id pub-id-type="pmid">8528557</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamei</surname><given-names>J</given-names></name><name><surname>Tanihara</surname><given-names>H</given-names></name><name><surname>Igarashi</surname><given-names>H</given-names></name><name><surname>Kasuya</surname><given-names>Y</given-names></name></person-group><article-title>Effects of N-methyl-D-aspartate antagonists on the cough reflex</article-title><source>Eur J Pharmacol</source><year>1989</year><volume>168</volume><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">2691260</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canning</surname><given-names>BJ</given-names></name></person-group><article-title>Central regulation of the cough reflex: therapeutic implications</article-title><source>Pulm Pharmacol Ther</source><year>2009</year><volume>22</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">19284972</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aouad</surname><given-names>MT</given-names></name><name><surname>Yazbeck-Karam</surname><given-names>VG</given-names></name><name><surname>Nasr</surname><given-names>VG</given-names></name><name><surname>El-Khatib</surname><given-names>MF</given-names></name><name><surname>Kanazi</surname><given-names>GE</given-names></name><name><surname>Bleik</surname><given-names>JH</given-names></name></person-group><article-title>A single dose of propofol at the end of surgery for the prevention of emergence agitation in children undergoing strabismus surgery during sevoflurane anesthesia</article-title><source>Anesthesiology</source><year>2007</year><volume>107</volume><fpage>733</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">18073548</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>IT</given-names></name><name><surname>Drewsen</surname><given-names>S</given-names></name><name><surname>Hannallah</surname><given-names>RS</given-names></name></person-group><article-title>Propofol or midazolam do not reduce the incidence of emergence agitation associated with desflurane anesthesia in children undergoing adenotonsillectomy</article-title><source>Paediatr Anaesth</source><year>2002</year><volume>12</volume><fpage>604</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">12358656</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Reves</surname><given-names>JG</given-names></name><name><surname>Glass</surname><given-names>PS</given-names></name><name><surname>Lubarsky</surname><given-names>DA</given-names></name><name><surname>McEvoy</surname><given-names>MD</given-names></name><name><surname>Martinez-Ruiz</surname><given-names>R</given-names></name></person-group><chapter-title>Intravenous anesthetics</chapter-title><person-group person-group-type="editor"><name><surname>Miller</surname><given-names>RD</given-names></name></person-group><source>Miller's anesthesia</source><edition>7th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Churchill Livingstone</publisher-name><year>2010</year><fpage>719</fpage><lpage>768</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>B</given-names></name><name><surname>White</surname><given-names>M</given-names></name><name><surname>Morton</surname><given-names>N</given-names></name><name><surname>Kenny</surname><given-names>GN</given-names></name></person-group><article-title>Pharmacokinetic model driven infusion of propofol in children</article-title><source>Br J Anaesth</source><year>1991</year><volume>67</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">1859758</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagel</surname><given-names>PS</given-names></name><name><surname>Warltier</surname><given-names>DC</given-names></name></person-group><article-title>Negative inotropic effects of propofol as evaluated by the regional preload recruitable stroke work relationship in chronically instrumented dogs</article-title><source>Anesthesiology</source><year>1993</year><volume>78</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">8424542</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>R</given-names></name><name><surname>Rathgeber</surname><given-names>J</given-names></name><name><surname>Bagdahn</surname><given-names>A</given-names></name><name><surname>Lange</surname><given-names>H</given-names></name><name><surname>Rieke</surname><given-names>H</given-names></name></person-group><article-title>Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients. A comparison with etomidate</article-title><source>Anaesthesia</source><year>1988</year><volume>43</volume><issue>Suppl</issue><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">3259092</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephan</surname><given-names>H</given-names></name><name><surname>Sonntag</surname><given-names>H</given-names></name><name><surname>Schenk</surname><given-names>HD</given-names></name><name><surname>Kettler</surname><given-names>D</given-names></name><name><surname>Khambatta</surname><given-names>HJ</given-names></name></person-group><article-title>Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease</article-title><source>Br J Anaesth</source><year>1986</year><volume>58</volume><fpage>969</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">3489478</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Schematic representation of anesthetic management from 5 min before the end of surgery to 3 min after the end of surgery.</p></caption><graphic xlink:href="kjae-66-120-g001"></graphic></fig><fig id="F2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Change in BIS during emergence from general anesthesia. Group C: 0.9% NaCl group, Group P: propofol group, BIS: bispectral index, T1: end of surgery, T2: immediately before extubation, T3: immediately after extubation, T4: 5 min after extubation, T5: 10 min after postanesthesia care unit admission. No significant differences between the groups.</p></caption><graphic xlink:href="kjae-66-120-g002"></graphic></fig><fig id="F3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Change in HR during emergence from general anesthesia. Group C: 0.9% NaCl group, Group P: propofol group, HR: heart rate, T0: before induction of anesthesia, T1: end of surgery, T2: immediately before extubation, T3: immediately after extubation, T4: 5 min after extubation, T5: 10 min after postanesthesia care unit admission. No significant differences between the groups.</p></caption><graphic xlink:href="kjae-66-120-g003"></graphic></fig><fig id="F4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Change in MAP during emergence from general anesthesia. Group C: 0.9% NaCl group, Group P: propofol group, MAP: mean arterial pressure, T0: before induction of anesthesia, T1: end of surgery, T2: immediately before extubation, T3: immediately after extubation, T4: 5 min after extubation, T5: 10 min after postanesthesia care unit admission. No significant differences between the groups.</p></caption><graphic xlink:href="kjae-66-120-g004"></graphic></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patients' and Operative Characteristics</p></caption><graphic xlink:href="kjae-66-120-i001"></graphic><table-wrap-foot><fn><p>Values are mean Â± SD or numbers. No significant differences between the groups.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison of the Occurrence and Grade of Cough</p></caption><graphic xlink:href="kjae-66-120-i002"></graphic><table-wrap-foot><fn><p>Values are number (proportion) or median (interquartile range). Group C: 0.9% NaCl group, Group P: propofol group, Grade 0: no cough, Grade 1: single cough with mild severity, Grade 2: cough persistence less than 5 sec with moderate severity, Grade 3: severe, persistent cough for more than 5 sec. <sup>*</sup>P &lt; 0.05 compared with Group C.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Recovery Profiles</p></caption><graphic xlink:href="kjae-66-120-i003"></graphic><table-wrap-foot><fn><p>Values are mean Â± SD or median (range). Group C: 0.9% NaCl group, Group P: propofol group, Time to eyes opening: time period from the end of surgery to eyes opening, Time to extubation: time period from the end of the surgery to extubation, Grade 0: deeply sedated and unresponsive, Grade 1: sedated but responsive to loud voice, Grade 2: sedated but responsive to normal voice, Grade 3: awake and responding. PACU: postanesthesia care unit. No significant differences between the groups.</p></fn></table-wrap-foot></table-wrap></floats-group></article>